The data presented in Figure 5 and Figure 6 indicated that kifunensine and swainsonine—inhibiting the mannose trimming steps taking place during the N-linked glycosylation process—lead to reduced N-linked glycosylation of PD-L1 in breast cancer cells. This evidence concerns the gene CD274 and breast carcinoma.